Your browser doesn't support javascript.
loading
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial.
Sadeghi, Anahita; Ali Asgari, Ali; Norouzi, Alireza; Kheiri, Zahedin; Anushirvani, Amir; Montazeri, Mahnaz; Hosamirudsai, Hadiseh; Afhami, Shirin; Akbarpour, Elham; Aliannejad, Rasoul; Radmard, Amir Reza; Davarpanah, Amir H; Levi, Jacob; Wentzel, Hannah; Qavi, Ambar; Garratt, Anna; Simmons, Bryony; Hill, Andrew; Merat, Shahin.
Afiliação
  • Sadeghi A; Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Ali Asgari A; Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Norouzi A; Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Science, Gorgan, Iran.
  • Kheiri Z; Department of Internal Medicine, Baharloo hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Anushirvani A; Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Montazeri M; Department of infectious diseases, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Hosamirudsai H; Department of Infectious Diseases, Baharloo Hospital, Tehran University of Medical Science, Tehran, Iran.
  • Afhami S; Department of infectious diseases, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran.
  • Akbarpour E; Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Aliannejad R; Department of Pulmonary and Critical Care, Shariati Hospital, Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Radmard AR; Department of Radiology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
  • Davarpanah AH; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, USA.
  • Levi J; Department of Emergency Medicine, Homerton University Hospital, London, UK.
  • Wentzel H; School of Public Health, Imperial College London, London, UK.
  • Qavi A; School of Public Health, Imperial College London, London, UK.
  • Garratt A; Cardiff and Vale University Health Board, Cardiff, UK.
  • Simmons B; Department of Infectious Disease, Imperial College London, London, UK.
  • Hill A; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
  • Merat S; Liver and Pancreatobiliary Diseases Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
J Antimicrob Chemother ; 75(11): 3379-3385, 2020 11 01.
Article em En | MEDLINE | ID: mdl-32812039

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Admissão do Paciente / Pneumonia Viral / Infecções por Coronavirus / Sofosbuvir / Betacoronavirus / Imidazóis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Admissão do Paciente / Pneumonia Viral / Infecções por Coronavirus / Sofosbuvir / Betacoronavirus / Imidazóis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã